Alkeran, powder und solutionsmittel zur Herstellung einer Injektions-/infusion solution

( ARTG ) Alkeran is indicated for the palliative treatment of multiple myeloma and advanced ovarian adenocarcinoma.‍‍‍‍‍‍​​​‍​​​​​​ Alkeran has a significant therapeutic effect in a proportion of patients suffering from advanced breast carcinoma and may be used in the treatment of polycythaemia vera. Alkeran has been used as an adjuvant to surgery in the management of breast carcinoma.